Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree that everyone has the right to buy and sell whenever they want but when you are a BOD and you know you have a huge dilution and you just released some great results you need to realize how bad that makes you look when you sell over 7 million shares. That is totally different then a regular stock holder like you and me. If he sold once things settled down, I would not have an issue. This company needs as much good PR as it can get and what he did does not help things even though it was his right.
I agree with you. I can live with the dilution. We knew it was coming and would significantly effect the stock price. We also knew why it had to happen, to settle prior agreements. What I can't live with and don't understand is how Dr. Lanza could sell over 7 million shares right after they released the early study results. It makes him and the company look really bad. Either he is not convinced on the study results or something else is going on behind the scenes. I assume he is a wealthy enough guy that he didn't need the money urgently. He could not have picked a worse time to sell and is a very poor PR move for him and the company.
My personal definition for myself is I plan on being in this stock for at least 3-5 years if everything goes as planned. By then we will have the study results and should be beginning or very close to earning signficant income. I also hope that over the next year there will be a JV announcement along with more confirmation of study results and the share price will rise significantly so anyone who purchased shares between .05-.25 will still have made a decent amount of money until the big rise in share price occurs in the next few years. There are alot of if's unfortunately but that is part of the fun of investing in this company. Huge risk but huge potential rewards.
12 million shares in 30 mins. I sure hope the bond holders got their shares and this is some of the selling. If not we could have a long week ahead of us. The good thing like everyone says, we are in for the long haul and now we can pick up some more soon at a much cheaper price.
correction, it is 10 business days which would make it next tues 2/7 that they would have to be released by if my math is correct. The problem is we don't know if the ones that are going to sell will do it quickly or very slowly. If they do it quickly they are shooting themselves in the foot since the price would drop quickly. If they do it slowly, it might keep the price down for several weeks. We all just want to get it over with then let the good news start to bring the price up. We all just need to keep hanging in there like most people in here have been saying. Good luck to us all.
If my math is correct it is not 10 more days before they release the shares. The filing was actually done on 1/24 and they stated they had 10 days from the filing. Even though the filing was publicly released today, the actual statement says it was filed on 1/24. If this is correct then the shares would have to be released by this friday. Does anyone else here have a different take on this?
Great article. I wasn't aware that they were in phase III trials in korea already. I am not sure how the KFDA works but the article suggests they could get approval by the KFDA in the next month. Does that mean they can start phase 4 trials there? or does that mean they can start officially treating patients in which case ACTC will start earning some significant income? Anyone on here know?
I was hoping Obama might bring up ACTC and how the vision improved in patients when he was talking about new medical technologies and supporting new companies. Oh well, no such luck. That would have helped the stock price a lot tomorrow, lol.
Gastro, I do agree with you on one point. The misspelling is unbelievable. I can understand a typo here and there but it is unbelievable how people can't spell. I'm assuming people who do some significant investing and are smart about how the way the market works are very intelligent. By the way Gastro, you misspelled arguing. It is not argueing. The previous poster had a great post about the study results and how it could go to $30 or more which I agree. When you finish your statement saying don't be immotional it just takes away from your post. It is emotional. I know this might be a strange post but if people are going to take you serious please have some decent spelling otherwise no one is going to take you serious. We all make typos but a lot of this is not typos. i must say, I am an idiot when it comes to intelligent investing and have been very impressed with the intelligence some people have on this board and the information they have access to. It is just hard to take some people serious when they make a post that sounds intelligent but the spelling is awful.
His question is actually a good question. When you look at a stock for the outstanding shares, ACTC now is 1.7 billion. As of tomorrow when it is approved, will it now say 2.7 billion or does it take a few days before it says that? It doesn't matter what the bond holders do but as of tomorrow will the outstanding shares say 2.7 billion?
I know it is out like I said. I was referring to the old fashioned way when physicians like myself actually get the Lancet and other journals in the mail. It is always released online 1 to 2 days before we get it in the mail. Physicians and scientists will actually get it on wednesday. Call us old fashioned but most of us still read the journals when we get them in the mail on not online, lol.
The article is coming out on wednesday in print but is available online now. Go to Thelancet.com and you will see the actual study that will be released in print on wednesday.
The article is coming out on wednesday in print but is available online now. Go to lancet.com and you will see the actual study that will be released in print on wednesday.
Rocky, I agree that it would be at least 2 years even for compassionate use approval and 2-4 years before they would bring in significant income. In that time they would likely get a JV as they could not distribute it in mass quantities without a major drug company that is ventured with them. The good thing is we all know that the pps is not based on your present earnings but what your future earnings are. If the studies as we go on this year confirm the same results than you are talking about potential income of 10-30 billion dollars in 5 years or so. Never mind some of the other things they are involved in that could begin to generate income around that time. This stock could shoot up quickly based on the future earnings in a few years, again if the studies continue to confirm the same results. People won't wait till the final approval or the income begins to role in.
I hope you are right. I bought another 50k shares this morning at .1530 once I saw the article.
hopefully, ABC,NBC, and CBS will pick up the story and run with it on tonights national news. That would be huge for the stock tomorrow.
so on quick read of the Lancet article, the cells had excellent implantation. There were no complications and the patients had slight visual improvement and definitely no worsening of vision. This is excellent news given how severe the vision loss was in these patients. This is only the begining but this is a great start. Hopefully the news media will pick up on this. Go ACTC
ES1, I disagree with you. I have read that several times and believe he meant that they have sent it to the review committee, they have sent back their comments and corrections and now they are finalizing the final result to be published in the next 2-3 weeks. Only time will tell what he meant but I don't believe he meant at all that they are just finalizing their paper and have not submitted anything yet to begin the review process. We will soon find out one way or the other.
then what is your purpose of repeatedly, several times every day saying the stock is going to 6 cents? I have no problem with you believing it but why do we need to hear it several times every day from you. You must have a reason for doing it so can you explain it to us why you do it?
There will likely be some sort of drop after the 24th when the shares are approved. The problem is no one knows when they are going to release their preliminary studies and when it is going to be in the journal or press. It could be tomorrow or it could be 3 weeks. I would kick myself if I sold now planning on the shares dropping after the 24th, then they release the news over the next week before that and the price skyrockets. I for one am not willing to take that chance. I'm holding and can live with a price drop if the studies don't come out till after that.
If the proxy vote on the 24th gets approved which we all believe it will, when do the bond holders actually get their shares? Do they get them the next day or does it take a week or so for all the legal issues to finalize before they release them to the bond holders?
Press release states
" Mr. Rabin will present at the Regenerative Medicine State of the industry briefing workshop at 8 a.m. PST, Level 2, Divisadero, and at 1:45 p.m. PST, Room Mission II, during two separate panels. Both presentations will take place on Tuesday, Jan. 10."
GR already presented this morning at 11 EST and is going to do it again at 4:45 according to their news release the other day. If he said anything dramatic earlier, we would have heard it by now.
speaking of proxy, has everyone received theirs? I still haven't received mine in the mail yet.
well Rabin begins to speak at the conference in an hour. I doubt he will say anything new or release any new information but if he is as positive as we saw from his press release earlier, we might see another pop in the stock.
Why are some people in here so worried whether it might peak at 15 cents or drop after the 24th once the additional shares are released. Most people in here from what I see believe the stock will go over 1 dollar this year and very possibly $10 and more in the next 5-8 years. Who cares if it goes back to 8 cents. You can't count on this stock following normal patterns of the 200 day or 50 day moving average anymore. They could release study results or a possible JV tomorrow or anytime in the next few weeks. Why would you risk selling knowing that if the science does work and they release the results, the stock is going to take off. If you are a day trader, it makes sense but if not, none of us are smart enough to know whether it might go up a few cents or go back to 8 cents. I am just holding on and not willing to risk that the news could come out any day or the next few weeks.
Ok the purpose of boards like this is to ask legitimate questions and for people to post legitimate information and honest opinions. I still haven't gotten my proxy vote in the mail yet. Like I have mentioned before, I presently own 400k shares and have no interest in selling because the potential is unbelievable. The question I have is if about 400 million shares are going to settle the lawsuits and they are asking for 1 billion more shares, that means they have about 600 million shares for their use. Supposedly according to their last quarterly report which I listened to, they had enough cash on hand to fund their studies for the next year. If the initial study is as good as they are leading us to believe and we are all hoping for, why would you need to dilute the shares 600 million more. If the study is good and you thought you would get a JV which they sound like they are close to doing, why dilute the stock more than the 400 million to settle the suits. A JV in the near future would fund the studies so it doesn't quiet make sense to me why dilute it further. If they didn't think they were going to get a JV in the next year until they got more study results I would totally understand. I would love to hear an intelligent response and not just someone who rips you any time you question the stock.
You are totally misreading what I am saying. I have said that I know the purpose of the phase 1 trial is safety and not vision results but we are all hoping for some visual improvement. If we don't get it in these patients I don't see the stock moving up significantly in the near future. If we do get it, it will skyrocket. Believe me I hope we see some improvement. I have nothing to benefit from the stock going down. I have 400k shares at a cost ave of 15 cents and don't plan on buying anymore no matter how low it goes. I have plenty of shares and am just hoping the early trials are very positive. I am just guessing what these results are going to show when they release them in the near future just as everyone else is giving an opinion on how low it will go. I didn't buy this stock worrying about whether it goes down 10 cents or doubles. I bought this stock because I see the potential of it going up to $10 or $50 a share in the next 5-10 years if the science works.
I suspect the suprise results they got were more cells actually implanted then they expected with the low dose they started with in these patients. For them it would be a very positive result but for us it doesn't help the stock price short term if there wasn't some vision improvement. I am hoping like all of you that there was some vision improvement. If there was, there won't be a short term bump and then a retreat. The stock will bump then continue to rise. Even though it is 3 or so years before they might get revenue, people will jump all over it knowing the potential revenue this company can have of 10's of billions of dollars. Yes it will take more studies but if you can show vision improvement in your first cohort of patients, that is ground breaking medical technology.
This is only my second post since I recently joined this board. There is one thing a lot of people missed when you watch the presentation by Dr. Schwartz. At one point in the Q&A he states " These patients are heroes because they clearly knew going into this it was very unlikely they would get any improvement in their vision or function". He goes on to say they did it to advance science. I take this as these patients probably didn't get any improvement in their vision. I understand that is not the purpose of thIs phase of the trials but we are all hoping that they did as it would cause the stock to skyrocket. My take is that the cells did implant and there were no safety issues at all which is positive. The reason why the patients asked to have their other eye done was it was likely they injected their worst eye since they were legally blind and since the cells did implant, the patients would want their better eye injected now to possibly prevent it from getting worse. This is still positive but it will likely mean that we are going to need more patients that aren't as severe to prove you can either stop the process or delay it.
Again, we are all just guessing at this point what might be going on but once this does get out in the press, this is my guess as to what we are going to see. It is still a positive but not quite what most of us are hoping for. We would all love to see some improvement in vision in these 2 patients but that is not the impression I got once I saw his presentation.
I own a lot of stock in this company and will continue to hold it. I just hope very soon they will start the next patients so they can see either improvement in less severe patients or a halt in the worsening of vision.
I have been following this message board for about a week and just joined. I own alot of this stock and am hopeful as all of you are that the trial results are very positive. Can I get your opinion on what realistically you think the stock could go to if the trial results are positive. My basic math says that if it is a 20 billion dollar market just in the U.S. that being conservative and say they can generate 10 billion in 5-6 years when they get approval and can ramp up. I understand there could be a buyout which I hope doesn't happen. A JV would be the best. With 2 billion shares at a PE of just 1 puts it at 5 dollars. Give it a PE of 10 and it puts it at $50. Plus you have the other corneal possibilities, myoblast and blood studies that could generate alot of money not including a world wide market. I also know a RS will likely happen but that doesn't change the math. Is there a flaw in my thinking and math? I am not worried about them running out of money if the results are positive because drug companies will be all over them trying to do a JV or buyout. Again I understand if the trial fails it is all for not. Thanks